Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Shruti Ahlawat, Asha Asha, Krishna Kant Sharma
Virus Research (2020) Vol. 286, pp. 198103-198103
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
Manoj Kumar Yadav, Indu Kumari, Bijender Singh, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 2, pp. 505-521
Open Access | Times Cited: 249
Promising bioactivities of postbiotics: A comprehensive review
Nazrana Rafique, Suhaib Yousuf Jan, Aamir Hussain Dar, et al.
Journal of Agriculture and Food Research (2023) Vol. 14, pp. 100708-100708
Open Access | Times Cited: 73
Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 44
Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium
Shruti Ahlawat, Pramod Kumar, Hari Mohan, et al.
Critical Reviews in Microbiology (2021) Vol. 47, Iss. 2, pp. 254-273
Closed Access | Times Cited: 78
SARS-CoV-2 and the Gastrointestinal Tract in Children
Maria Giovanna Puoti, Anna Rybak, Fevronia Kiparissi, et al.
Frontiers in Pediatrics (2021) Vol. 9
Open Access | Times Cited: 71
Lost microbes of COVID-19:Bifidobacterium,Faecalibacteriumdepletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
Sabine Hazan, Neil Stollman, Hüseyin Sancar Bozkurt, et al.
BMJ Open Gastroenterology (2022) Vol. 9, Iss. 1, pp. e000871-e000871
Open Access | Times Cited: 66
Gut‐lung axis and asthma: A historical review on mechanism and future perspective
Xiuling Song, Juan Liang, Shao‐Zhu Lin, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 12
Neurotropic Viruses, Astrocytes, and COVID-19
Petra Tavčar, Maja Potokar, Marko Kolenc, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 53
Lactoferrin for the treatment of COVID‑19 (Review)
Yidan Wang, Puxiu Wang, H. J. Wang, et al.
Experimental and Therapeutic Medicine (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 52
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4942-4942
Open Access | Times Cited: 48
Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
Chiara Corpetti, Alessandro Re, Luisa Seguella, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6893-6903
Open Access | Times Cited: 48
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19
Alessandra Oliva, Maria Claudia Miele, Federica Di Timoteo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study
Zeno Pasquini, Iacopo Barocci, Lucia Brescini, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 31-36
Open Access | Times Cited: 42
Biomedical and Nutritional Applications of Lactoferrin
Carlotta Coccolini, Elisa Berselli, Cristina Blanco-Llamero, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 5
Open Access | Times Cited: 16
Gut microbiota and its metabolic products in acute respiratory distress syndrome
Dongwei Zhang, Jiali Lu, Bi-Ying Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection
Sinjini Patra, Shivam Saxena, Nilanjan Sahu, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 13, Iss. 4, pp. 1138-1156
Open Access | Times Cited: 36
Coronavirus disease 2019 and the gut–lung axis
Dan Dan Zhou, Qiu Wang, Hanmin Liu
International Journal of Infectious Diseases (2021) Vol. 113, pp. 300-307
Open Access | Times Cited: 33
The imbalance of pulmonary Th17/Treg cells in BALB/c suckling mice infected with respiratory syncytial virus-mediated intestinal immune damage and gut microbiota changes
Jiling Liu, Yixuan Huang, Nian Liu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 4
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission
Hafez Al-Momani, Andrew Nelson, Hadeel Al Balawi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Relationship Between Gut Microbiota and the Clinical Course of COVID-19 Disease
Antonija Jonjić, Ivan Dolanc, Goran Slivšek, et al.
Viruses (2025) Vol. 17, Iss. 4, pp. 520-520
Open Access
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Mengling Yang, Yang Yang, Qingnan He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
Shima Moradi‐Kalbolandi, Keivan Majidzadeh‐A, Mohadeseh Haji Abdolvahab, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 13, Iss. 5, pp. 1239-1253
Open Access | Times Cited: 28
Functional profiling of COVID-19 respiratory tract microbiomes
Niina Haiminen, Filippo Utro, Ed Seabolt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19
Laura Linares-García, María E. Cárdenas-Barragán, Winston Hernández-Ceballos, et al.
Journal of Clinical Gastroenterology (2022) Vol. 56, Iss. 4, pp. 285-298
Open Access | Times Cited: 21
Analysis of SARS-CoV-2 viral loads in stool samples and nasopharyngeal swabs from COVID-19 patients in the United Arab Emirates
Mariane Daou, Hussein Kannout, Mariam Khalili, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274961-e0274961
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top